The insider sales are immaterial and likely pre-planned. The GSK acquisition at $124/share is the dominant event — traders should focus on deal closing risks (regulatory approval, tender condition) rather than this insider activity. Monitor for any insider purchases or unusual option activity that might signal deal skepticism.
Price Chart
Executive Summary
Nuvalent CEO James Porter exercised 30,000 options at $18.93/share and sold 12,495 shares on the open market for $1.1M, while CFO Alexandra Balcom sold 960 shares for $91K. These sales occurred just one day after the announcement of GSK's $10.6B acquisition of Nuvalent at $124/share, suggesting the CEO's sale was likely pre-planned (option exercise + sell-to-cover) rather than a bearish signal. The cluster is trivial relative to the $9.7B market cap (0.01%) and is overshadowed by the transformative acquisition premium.
Key Financial Metrics
Key Facts
- CEO Porter exercised 30,000 options at $18.93/share ($567,900) and sold 12,495 shares at $87.97 ($1.1M) on June 8, 2026
- CFO Balcom sold 960 shares at $94.87 ($91K) on June 1, 2026
- Total insider sales of $1.19M represent ~0.01% of Nuvalent's $9.7B market cap
- GSK acquisition at $124/share (43% premium to recent price) was announced June 9, 2026 — one day after the CEO's sale
- The CEO's option exercise and sale pattern is consistent with routine tax-related selling, not informed bearishness
Financial Impact
Insider sales of $1.19M are trivial relative to $9.7B market cap (0.01%)
Risk Factors
- Insider sales could be misinterpreted as bearish by retail traders unaware of the acquisition context
- CEO's option exercise adds 30,000 shares to the float, but this is negligible
- The acquisition may face regulatory hurdles or competing bids
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-NUVL-1781123508183 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Jul 27, 2026 9w ago | 15-12G | — | awaiting T+5 | — | — |
Jul 15, 2026 11w ago | 25-NSE | $123.96 $123.96 | · 0.00% | ▲ +0.98% | — |
Jul 15, 2026 11w ago | 8-K | $123.96 $123.96 | · 0.00% | ▲ +0.98% | — |
Jul 8, 2026 12w ago | Insider Cluster | $123.80 $123.96 | ▲ +0.13% | ▼ −0.73% | — |
Jul 6, 2026 12w ago | Insider Cluster | $123.72 $123.90 | ▲ +0.15% | ▼ −0.34% | — |
Jun 11, 2026 16w ago | Insider Cluster | $123.25 $123.43 | ▲ +0.15% | ▼ −0.53% | — |
Jun 10, 2026 16w ago | Insider Cluster | $123.45 $123.36 | ▼ −0.07% | ▼ −0.51% | — |
Jun 9, 2026 16w ago | 8-K | $123.25 $123.35 | ▲ +0.08% | ▼ −2.33% | — |
May 7, 2026 21w ago | 8-K | $102.40 $105.22 | ▲ +2.75% | ▲ +1.25% | — |
Apr 29, 2026 22w ago | Insider Cluster | $99.10 $101.47 | ▲ +2.39% | ▼ −0.72% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access